(Press-News.org) Scientific papers suggesting that smokers are less likely to fall ill with covid-19 are being discredited as links to the tobacco industry, reveals an investigation by The BMJ today.
Journalists Stéphane Horel and Ties Keyzer report on undisclosed financial links between certain scientific authors and the tobacco and e-cigarette industry in a number of covid research papers.
In April 2020, two French studies (shared as preprints before formal peer review) suggested that nicotine might have a protective effect against covid-19 - dubbed the "nicotine hypothesis."
The stories made headlines worldwide and led to concern that decades of tobacco control could be undermined.
It has since been roundly disproved that smoking protects against covid-19, and several studies show that smoking, when adjusted for age and sex, is associated with an increased chance of covid-19 related death.
Horel and Keyzer point out that one of the study authors, Professor Jean-Pierre Changeux, has a history of receiving funding from the Council for Tobacco Research, whose purpose was to fund research that would cast doubt on the dangers of smoking and focus on the positive effects of nicotine.
From 1995 to 1998, tobacco industry documents show that Changeux's laboratory received $220,000 (£155,000; €180,000) from the Council for Tobacco Research.
Changeux assured The BMJ that he has not received any funding linked "directly or indirectly with the tobacco industry" since the 1990s.
In late April 2020, Greek researcher, Konstantinos Farsalinos, was the first to publish the "nicotine hypothesis" formally in a journal, in an editorial in Toxicology Reports.
The journal's editor in chief, Aristidis Tsatsakis featured as a co-author, as did A Wallace Hayes, a member of Philip Morris International's scientific advisory board in 2013, who has served as a paid consultant to the tobacco company.
Another co-author is Konstantinos Poulas, head of the Molecular Biology and Immunology Laboratory at the University of Patras, where Farsalinos is affiliated.
The laboratory has received funding from Nobacco, the market leader in Greek e-cigarettes and the exclusive distributor of British American Tobacco's nicotine delivery systems since 2018.
Neither Farsalinos nor Poulas has ever declared this Nobacco funding in their published scientific articles.
Yet Horel and Keyzer show that two grants were attributed in 2018 by the Foundation for a Smoke Free World - a non-profit established by Philip Morris International in 2017 - to "Patras Science Park."
The grants, whose amounts are not disclosed on the foundation's website, but tax documents show came close to €83,000, went to NOSMOKE, a university start-up incubator headed by Poulas, which markets an "organic" vaping product.
Last month, the European Respiratory Journal retracted a paper co-written by Poulas and Farsalinos, among others, after two authors failed to disclose conflicts of interest.
The retracted article had found that "current smoking was not associated with adverse outcome" in patients admitted to hospital with covid, and it claimed that smokers had a significantly lower risk of acquiring the virus.
The foundation has invested heavily in the covid-19/nicotine hypothesis, say Horel and Keyzer.
In June 2020 it set aside €900,000 for research "to better understand the associations between smoking and/or nicotine use, and covid-19 infection and outcome."
Its request stated that the pandemic offered "both an opportunity and a challenge for individuals to quit smoking or transition to reduced risk nicotine products."
They conclude: "In 2021, amid a global lung disease pandemic, tobacco industry figures are increasingly pushing the narrative of nicotine as the solution to an addiction that they themselves created, with the aim of persuading policy makers to give them ample room to market their "smoke-free" products. This makes studies on the hypothetical virtues of nicotine most welcome indeed."
INFORMATION:
Externally peer reviewed? Yes
Evidence type: Investigation
Subject: Research integrity
New York, NY (June 2, 2021) - A phase 3 clinical trial co-led by Mount Sinai researchers is the first to show that immunotherapy after surgery to remove bladder cancer can reduce the risk of relapse for patients who are at high risk of their cancer returning in a deadly metastatic form, according to results published in The New England Journal of Medicine. The immunotherapy nivolumab was used as an adjuvant therapy, which is given after surgery in the hopes of maximizing its effectiveness.
The randomized trial, named "Checkmate 274," showed that using nivolumab increased these patients' chance of staying cancer free after surgery compared to patients who received a placebo. The average length of time before relapse nearly doubled ...
June 5, 2021 marks the 40th anniversary of the first report of AIDS cases and the onset of the American AIDS epidemic. In a new, thought-provoking paper in the New England Journal of Medicine, Professor Ronald Bayer and co-author Gerald Oppenheiner capture the experiences of the physicians who were central to the AIDS epidemic. In the words of the doctors, they relay what it meant to look back after 40 years and how they "aged together."
The doctors called their experiences extraordinary and the conditions demanding, under which they performed their duties and treated their patients. They speak of their work as "in the trenches," giving their careers immediate meaning and value that they never expected. As several physicians expressed, ...
MINNEAPOLIS - Deep brain stimulation continues to be effective in people with Parkinson's disease 15 years after the device is implanted, according to a study published in the June 2, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers found that compared to before deep brain stimulation, study participants continued to experience significant improvement in motor symptoms, which are symptoms that affect movement, as well as a reduction in medications 15 years later.
Parkinson's disease can progressively affect speech, walking and balance due to a gradual reduction of a chemical in the brain called dopamine. Parkinson's symptoms of muscle stiffness, tremor and slowness ...
MINNEAPOLIS - Older people with type 1 diabetes who have been to the hospital at some point for both low and high blood sugar levels may be at six times greater risk for developing dementia years later. The research is published in the June 2, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that people with type 1 diabetes who visit the hospital for just one of the blood sugar extremes may also be at greater risk for developing dementia.
Type 1 diabetes is a chronic condition in which the pancreas produces little or no insulin.
Hypoglycemia is low blood glucose, or the main sugar in blood, that may result in loss of consciousness. Hyperglycemia results from insulin deficiency or extremely ...
URBANA, Ill. -When pigs get hit with significant illnesses during key stages of pregnancy, their immune response may negatively affect developing piglets, making them less productive on the farm. New research from the University of Illinois shows that when those piglets - especially males - experience a second stressor in early life, they are at higher risk of neurodevelopmental and other neurological anomalies, putting them at an even greater disadvantage in production settings.
"With more information about maternal illness, what we call maternal immune activation, we can make better decisions about how to handle these types of immune challenges within animal production settings," says Marissa Keever-Keigher, doctoral student ...
In a new study, University of Maine researchers found that culture helps humans adapt to their environment and overcome challenges better and faster than genetics.
After conducting an extensive review of the literature and evidence of long-term human evolution, scientists Tim Waring and Zach Wood concluded that humans are experiencing a "special evolutionary transition" in which the importance of culture, such as learned knowledge, practices and skills, is surpassing the value of genes as the primary driver of human evolution.
Culture is an under-appreciated factor in human evolution, Waring ...
Icebergs crumbling into the sea may be what first come to mind when imagining the most dramatic effects of global warming.
But new University of Arizona-led research, published in Geophysical Research Letters, suggests that more record-breaking temperatures will actually occur in the tropics, where there is a large and rapidly growing population.
"People recognize that polar warming is much faster than the mid-latitudes and tropics; that's a fact," said lead study author Xubin Zeng, director of the UArizona Climate Dynamics and Hydrometeorology Center and a professor of atmospheric sciences. "The second fact is that the warming over land is greater than over ...
People of color are more than twice as likely to die after a traumatic brain injury as white people, according to a new retrospective review from Oregon Health & Science University.
The study published today in the journal Frontiers in Surgery.
In the report, "Racial and Ethnic Inequities in Mortality During Hospitalization for Traumatic Brain Injury: A Call to Action," the researchers analyzed more than a decade of data related to the health outcomes and demographics of thousands of patients treated for traumatic head injuries at OHSU Hospital, one of two Level 1 trauma centers in the state.
They found a clear delineation of worse outcomes for people of color.
"We have a societal and professional duty to recognize and accept that the effects of structural ...
Hydrogels are commonly used inside the body to help in tissue regeneration and drug delivery. However, once inside, they can be challenging to control for optimal use. A team of researchers in the Department of Biomedical Engineering at Texas A&M University is developing a new way to manipulate the gel -- by using light.
Graduate student Patrick Lee and Dr. Akhilesh Gaharwar, associate professor, are developing a new class of hydrogels that can leverage light in a multitude of ways. Light is a particularly attractive source of energy as it can be confined to a predefined area as well as be finetuned by the time or intensity of light exposure. Their work was recently published in the journal Advanced Materials.
Light?responsive hydrogels are an ...
OAKLAND, Calif. -- In patients with insulin-treated type 2 diabetes, the use of continuous glucose monitors is associated with better blood sugar control and fewer visits to the emergency room for hypoglycemia, a Kaiser Permanente study published June 2 in the journal JAMA found.
The monitors have previously been shown to improve glucose control for patients with type 1 diabetes. Continuous glucose monitors are now the standard of care for these patients.
"The improvement in blood sugar control was comparable to what a patient might experience after starting a new diabetes medication," said the study's lead author Andrew J. Karter, PhD, a senior research scientist with the Kaiser Permanente Northern California ...
